Navigation Links
Prevalence of COPD Greater Than Thought
Date:8/30/2007

Smoking, air pollution, aging are main causes of spread worldwide, study says

THURSDAY, Aug. 30 (HealthDay News) -- There are more people around the world suffering from chronic obstructive pulmonary disease (COPD) than previously thought, an international team of researchers reports.

Worse yet, those numbers are bound to increase as the world's population continues to age, claims the study in the Sept. 1 issue of The Lancet.

"COPD is much more common than previous estimates would suggest," said study author Dr. A. Sonia Buist, chief of the division of pulmonary and critical care medicine at Oregon Health & Science University. "We did the study, because there is a huge disconnect between the public and the public health perception of the burden of COPD, and the reality."

COPD is under-diagnosed and under-treated, Buist said.

"COPD is a cumulative response of the lungs to the burden of all that's breathed in over a lifetime," she said. "As populations age, the prevalence of COPD and the burden of COPD is going to increase significantly."

In the study, Buist's group collected data on 9,425 people aged 40 and over who hailed from 12 different countries.

They found that the overall prevalence of severe COPD was 10.1 percent. Among men, it was 11.8 percent and for women, 8.5 percent. These figures contrast with another recent study that placed the overall burden of COPD at 4.3 percent, Buist noted.

In the United States, the overall prevalence of serious COPD is 10.1 percent, the researchers reported.

The number of people with COPD varied throughout world. Cape Town, South Africa, had the highest prevalence of COPD, with 22.2 percent of men and 16.7 percent of women affected, while Hanover, Germany, had the lowest prevalence, with 8.6 percent of men and 3.7 percent of women with serious COPD.

The difference in COPD between men and women is mostly due
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. High Prevalence of AIDS among Indian Truck drivers
2. Survey Reveals Alarming Prevalence Rates of Diabetes among US Adolescents
3. HIV Prevalence In Ethiopian Women Greater Than National Average
4. Prevalence Of AIDS Goes Down In Illinois
5. HIV Prevalence in South Africa May be on Decline
6. Prevalence of Self-reported Snoring, Sleep-disordered Breathing in Military
7. Decrease in AIDS prevalence rate in Kenya
8. Prevalence of Celiac disease in children with type 1 diabetes
9. Prevalence of AIDS Cases in UAE is Low
10. When prevalence Makes for Disparity in AIDS Care
11. Thailand Approves Strategic Plan To Reduce HIV Prevalence Among Youth
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 55198 1The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 55198 2New Study of House Health Reform Bill 3A California Faces Over 243 7 Billion in Medicare Funded Nursing Home Cuts Over Ten Years 55196 1New Study of House Health Reform Bill 3A California Faces Over 243 7 Billion in Medicare Funded Nursing Home Cuts Over Ten Years 55196 2Testosterone Therapy May Help Men With Heart Failure 55194 1Testosterone Therapy May Help Men With Heart Failure 55194 2Testosterone Therapy May Help Men With Heart Failure 55194 3